Skip to content

Use of Antibacterial Cement in Infected Dentin

Phase 1 Study of Clinical and Radiographic Success of Antibacterial Cement in Infected Dentin of Deciduous Teeth

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01449136
Acronym
AC
Enrollment
45
Registered
2011-10-10
Start date
2008-01-31
Completion date
2010-02-28
Last updated
2011-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries

Keywords

Antibacterial agents, Deciduous Teeth, Clinical Trial

Brief summary

Dental materials with antibacterial properties can prevent the harmful effects caused by oral cariogenic bacteria. This double-blind controlled clinical trial evaluated the performance of antibacterial cement for sealing infected dentin in atraumatic restorations of primary molars.

Detailed description

The study enrolled 45 children (45 teeth) between 5 and 8 years of age, of both genders, divided into two groups. In group A (GA; n=22), the cavities were lined with conventional glass ionomer cement (Vidrion F®) and in group B (GB; n=23), with antibacterial cement (Vidrion F® containing 1% each of metronidazole, ciprofloxacin, and cefaclor). Both groups were restored with Ketac Molar Easymix®. Molars with carious lesions on the inner half of dentin without clinical or radiographic pulp damage were selected. Patients were evaluated clinically (for pain, fistulas, or mobility) and radiographically (area of caries, periapical region, and furcation of teeth) after 1, 3, 6, and 12 months.

Interventions

OTHERAntibacterial cement

Glass ionomer cement containing 1% each of metronidazole, ciprofloxacin, and cefaclor

Sponsors

University of Pernambuco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
5 Years to 8 Years
Healthy volunteers
No

Inclusion criteria

* signed consent from a parent or guardian; * primary molars with carious lesions on the inner half of dentin; * access of caries lesions to dentin spoons.

Exclusion criteria

* damaged pulp determined clinically (for pain, fistulas, tooth mobility); * damaged pulp determined radiography (bone or dental pathology); * children taking antibiotics; * children who refused the treatment; * children had systemic disease.

Design outcomes

Primary

MeasureTime frameDescription
number of successful restorations with a dental liner with antibioticsdifferences of overall success between baseline and the evaluations performed at 1, 3, 6, and 12 months.The absence of pain, fistulas, and mobility throughout the study was considered clinical success and the decreased or unchanged area of caries (obtained by a software to accurately measure distances between anatomical points selected by the operator of radiolucent zone beneath the restoration) and no bone or dental disorder was detected was considered radiographic success. Overall success was defined as clinical and radiographic success being achieved simultaneously.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026